Evidence map›Paper›PMID 25561081›Full record

ReviewNature reviews. Nephrology2015

Cardiac imaging in patients with chronic kidney disease.

Diana Y Y Chiu, Darren Green, Nik Abidin, Smeeta Sinha, Philip A Kalra

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Cardiac Troponins in Kidney Disease.European cardiology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diana Y Y ChiuInstitute of Population Health, Manchester Academic Health Science Centre, The University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
Darren GreenInstitute of Population Health, Manchester Academic Health Science Centre, The University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
Nik AbidinDepartment of Cardiology, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.
Smeeta Sinha1] Institute of Population Health, Manchester Academic Health Science Centre, The University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK. [2] Department of Renal Medicine, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.
Philip A Kalra1] Institute of Population Health, Manchester Academic Health Science Centre, The University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK. [2] Department of Renal Medicine, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with chronic kidney disease (CKD) carry a high cardiovascular risk. In this patient group, cardiac structure and function are frequently abnormal and 74% of patients with CKD stage 5 have left ventricular hypertrophy (LVH) at the initiation of renal replacement therapy. Cardiac changes, such as LVH and impaired left ventricular systolic function, have been associated with an unfavourable prognosis. Despite the prevalence of underlying cardiac abnormalities, symptoms may not manifest in many patients. Fortunately, a range of available and emerging cardiac imaging tools may assist with diagnosing and stratifying the risk and severity of heart disease in patients with CKD. Moreover, many of these techniques provide a better understanding of the pathophysiology of cardiac abnormalities in patients with renal disease. Knowledge of the currently available cardiac imaging modalities might help nephrologists to choose the most appropriate investigative tool based on individual patient circumstances. This Review describes established and emerging cardiac imaging modalities in this context, and compares their use in CKD patients with their use in the general population.

Indexed as

Cardiac Imaging TechniquesAlgorithmsCoronary StenosisHeart DiseasesHumansRenal Insufficiency, Chronic

Identifiers

PMID25561081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.